Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 7, 2022 (Week 18)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 106 437 4,276 2,785 7 13 103 68
New England - 17 91 119 - 1 1 -
Connecticut - 6 20 32 - 0 - -
Maine - 7 33 28 - 0 - -
Massachusetts - 9 - 35 - 0 - -
New Hampshire - 4 22 11 - 1 1 -
Rhode Island - 4 8 9 - 1 - -
Vermont - 3 8 4 - 0 - -
Middle Atlantic 41 86 703 413 4 6 29 19
New Jersey 2 12 71 79 2 3 8 16
New York (excluding New York City) 17 46 260 110 1 3 14 3
New York City 8 22 165 116 - 6 - -
Pennsylvania 14 19 207 108 1 2 7 -
East North Central 8 92 810 408 - 4 31 9
Illinois N NC N N N NC N N
Indiana - 28 139 129 - 0 - -
Michigan 2 18 152 98 - 2 3 3
Ohio - 41 385 175 - 4 28 6
Wisconsin 6 19 134 6 - 0 - -
West North Central - 32 286 149 - 2 8 17
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri - 22 189 97 - 2 8 9
Nebraska - 7 39 22 - 0 - -
North Dakota - 4 22 11 - 0 - -
South Dakota - 7 36 19 - 1 - 8
South Atlantic 13 73 463 504 - 5 7 4
Delaware 1 5 35 18 - 0 - -
District of Columbia - 2 9 8 - 0 - -
Florida 12 26 234 171 - 3 7 3
Georgia - 18 34 159 - 0 - -
Maryland - 11 1 70 - 1 - 1
North Carolina N NC N N N NC N N
South Carolina - 25 123 1 - 3 - -
Virginia - 1 3 5 - 0 - -
West Virginia - 11 24 72 - 0 - -
East South Central 3 43 364 304 - 2 2 2
Alabama - 19 110 87 - 1 1 -
Kentucky - 12 64 32 - 2 1 2
Mississippi 3 8 63 48 - 0 - -
Tennessee - 26 127 137 - 0 - -
West South Central - 109 461 321 - 2 8 13
Arkansas - 10 78 42 - 1 1 -
Louisiana - 29 58 83 - 1 - -
Oklahoma N NC N N N NC N N
Texas - 99 325 196 - 2 7 13
Mountain 41 94 1,033 517 3 2 13 4
Arizona 19 48 480 211 - 1 2 2
Colorado 19 28 223 101 1 1 2 -
Idaho N NC N N N NC N N
Montana - 5 30 17 - 1 - -
Nevada 1 10 96 68 - 1 1 1
New Mexico - 16 127 55 - 0 - -
Utah 2 12 77 45 2 2 8 1
Wyoming - 3 - 20 - 0 - -
Pacific - 12 65 50 - 2 4 -
Alaska - 11 55 41 - 2 4 -
California N NC N N N NC N N
Hawaii - 3 10 9 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 106 437 4,276 2,786 7 13 103 68
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.